WO2002044417A3 - Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer - Google Patents
Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer Download PDFInfo
- Publication number
- WO2002044417A3 WO2002044417A3 PCT/US2001/044495 US0144495W WO0244417A3 WO 2002044417 A3 WO2002044417 A3 WO 2002044417A3 US 0144495 W US0144495 W US 0144495W WO 0244417 A3 WO0244417 A3 WO 0244417A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- prostate cancer
- diagnosis
- inhibitor
- treatment
- nucleic acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ526706A NZ526706A (en) | 2000-11-28 | 2001-11-28 | Use of inhibitor of differentiation markers ID-1 and ID-3 for the diagnosis and prognosis of prostate cancer |
IL15595301A IL155953A0 (en) | 2000-11-28 | 2001-11-28 | Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
EP01987116A EP1356107A2 (en) | 2000-11-28 | 2001-11-28 | Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
CA002429721A CA2429721A1 (en) | 2000-11-28 | 2001-11-28 | Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
MXPA03004577A MXPA03004577A (en) | 2000-11-28 | 2001-11-28 | Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer. |
JP2002546765A JP2004526424A (en) | 2000-11-28 | 2001-11-28 | Expression analysis of differentiation inhibitor nucleic acids and polypeptides useful for diagnosis and treatment of prostate cancer |
BR0115689-6A BR0115689A (en) | 2000-11-28 | 2001-11-28 | Nucleic acid and polypeptide differentiation inhibitor expression analysis useful in the diagnosis and treatment of prostate cancer |
HU0303890A HUP0303890A3 (en) | 2000-11-28 | 2001-11-28 | Expression amalysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
AU2002239363A AU2002239363A1 (en) | 2000-11-28 | 2001-11-28 | Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
NO20032393A NO20032393L (en) | 2000-11-28 | 2003-05-27 | Expression analysis of inhibitor of differentiation of nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25337400P | 2000-11-28 | 2000-11-28 | |
US60/253,374 | 2000-11-28 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2002044417A2 WO2002044417A2 (en) | 2002-06-06 |
WO2002044417A3 true WO2002044417A3 (en) | 2003-07-24 |
WO2002044417A9 WO2002044417A9 (en) | 2003-11-20 |
Family
ID=22959998
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/044495 WO2002044417A2 (en) | 2000-11-28 | 2001-11-28 | Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
Country Status (14)
Country | Link |
---|---|
US (1) | US20020182614A1 (en) |
EP (1) | EP1356107A2 (en) |
JP (1) | JP2004526424A (en) |
AU (1) | AU2002239363A1 (en) |
BR (1) | BR0115689A (en) |
CA (1) | CA2429721A1 (en) |
HU (1) | HUP0303890A3 (en) |
IL (1) | IL155953A0 (en) |
MX (1) | MXPA03004577A (en) |
NO (1) | NO20032393L (en) |
NZ (1) | NZ526706A (en) |
PL (1) | PL365794A1 (en) |
WO (1) | WO2002044417A2 (en) |
ZA (1) | ZA200304997B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001290949A1 (en) * | 2000-09-14 | 2002-03-26 | California Pacific Medical Center | Id-1 and id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma |
BR0316111A (en) * | 2002-11-21 | 2005-09-13 | Wyeth Corp | Methods to diagnose rcc and other solid tumors |
US7643943B2 (en) | 2003-02-11 | 2010-01-05 | Wyeth Llc | Methods for monitoring drug activities in vivo |
CA2523798A1 (en) * | 2003-04-29 | 2004-11-11 | Wyeth | Methods for prognosis and treatment of solid tumors |
JP2007503834A (en) * | 2003-09-05 | 2007-03-01 | サノフィ パストゥール リミテッド | Multi-antigen vector for melanoma |
KR20090006837A (en) * | 2006-03-24 | 2009-01-15 | 페노미넘 디스커버리스 인코포레이티드 | Blomarkers useful for diagnosing prostate cancer, and methods thereof |
KR20220126661A (en) * | 2021-03-08 | 2022-09-16 | (주)아큐레시스바이오 | Composition for diagnosing pancreatic cancer |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997005283A1 (en) * | 1995-08-01 | 1997-02-13 | Sloan-Kettering Institute For Cancer Research | Id AS A DIAGNOSTIC MARKER IN TUMOR CELLS |
WO1999035244A1 (en) * | 1998-01-09 | 1999-07-15 | President And Fellows Of Harvard College | IMMORTALIZATION OF PRIMARY HUMAN KERATINOCYTES BY THE HELIX-LOOP-HELIX PROTEIN, Id-1 |
WO1999037811A1 (en) * | 1998-01-21 | 1999-07-29 | Urocor, Inc. | Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
WO2002022858A1 (en) * | 2000-09-14 | 2002-03-21 | The Regents Of The University Of California | Id-1 and id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma |
-
2001
- 2001-11-28 HU HU0303890A patent/HUP0303890A3/en unknown
- 2001-11-28 AU AU2002239363A patent/AU2002239363A1/en not_active Abandoned
- 2001-11-28 BR BR0115689-6A patent/BR0115689A/en not_active IP Right Cessation
- 2001-11-28 MX MXPA03004577A patent/MXPA03004577A/en unknown
- 2001-11-28 NZ NZ526706A patent/NZ526706A/en unknown
- 2001-11-28 US US09/996,529 patent/US20020182614A1/en not_active Abandoned
- 2001-11-28 EP EP01987116A patent/EP1356107A2/en not_active Withdrawn
- 2001-11-28 IL IL15595301A patent/IL155953A0/en unknown
- 2001-11-28 WO PCT/US2001/044495 patent/WO2002044417A2/en not_active Application Discontinuation
- 2001-11-28 CA CA002429721A patent/CA2429721A1/en not_active Abandoned
- 2001-11-28 JP JP2002546765A patent/JP2004526424A/en active Pending
- 2001-11-28 PL PL01365794A patent/PL365794A1/en not_active Application Discontinuation
-
2003
- 2003-05-27 NO NO20032393A patent/NO20032393L/en unknown
- 2003-06-26 ZA ZA200304997A patent/ZA200304997B/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997005283A1 (en) * | 1995-08-01 | 1997-02-13 | Sloan-Kettering Institute For Cancer Research | Id AS A DIAGNOSTIC MARKER IN TUMOR CELLS |
WO1999035244A1 (en) * | 1998-01-09 | 1999-07-15 | President And Fellows Of Harvard College | IMMORTALIZATION OF PRIMARY HUMAN KERATINOCYTES BY THE HELIX-LOOP-HELIX PROTEIN, Id-1 |
WO1999037811A1 (en) * | 1998-01-21 | 1999-07-29 | Urocor, Inc. | Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
WO2002022858A1 (en) * | 2000-09-14 | 2002-03-21 | The Regents Of The University Of California | Id-1 and id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma |
Non-Patent Citations (4)
Title |
---|
EID M A ET AL: "EXPRESSION OF EARLY GROWTH RESPONSE GENES IN HUMAN PROSTATE CANCER", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 58, 1 June 1998 (1998-06-01), pages 2461 - 2468, XP001108922, ISSN: 0008-5472 * |
ISRAEL M A ET AL: "ID GENE EXPRESSION AS A KEY MEDIATOR OF TUMOUR CELL BIOLOGY", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 59, no. 7, 1 April 1999 (1999-04-01), pages 1726S - 1730S, XP002943952, ISSN: 0008-5472 * |
NORTON J D ET AL: "ID HELIX-LOOP-HELIX PROTEINS IN CELL GROWTH AND DIFFERENTIATION", TRENDS IN CELL BIOLOGY, ELSEVIER SCIENCE LTD, XX, vol. 8, February 1998 (1998-02-01), pages 58 - 65, XP001027114, ISSN: 0962-8924 * |
NORTON JOHN D: "ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis.", JOURNAL OF CELL SCIENCE, vol. 113, no. 22, November 2000 (2000-11-01), pages 3897 - 3905, XP002230525, ISSN: 0021-9533 * |
Also Published As
Publication number | Publication date |
---|---|
JP2004526424A (en) | 2004-09-02 |
HUP0303890A2 (en) | 2004-03-01 |
NO20032393D0 (en) | 2003-05-27 |
US20020182614A1 (en) | 2002-12-05 |
HUP0303890A3 (en) | 2006-03-28 |
BR0115689A (en) | 2004-02-10 |
MXPA03004577A (en) | 2003-09-04 |
NO20032393L (en) | 2003-07-03 |
EP1356107A2 (en) | 2003-10-29 |
PL365794A1 (en) | 2005-01-10 |
IL155953A0 (en) | 2003-12-23 |
ZA200304997B (en) | 2004-09-27 |
AU2002239363A1 (en) | 2002-06-11 |
CA2429721A1 (en) | 2002-06-06 |
NZ526706A (en) | 2005-03-24 |
WO2002044417A9 (en) | 2003-11-20 |
WO2002044417A2 (en) | 2002-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002044418A3 (en) | Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer | |
WO2001070979A3 (en) | Genes, compositions, kits, and method for identification, assessment, prevention and therapy of ovarian cancer | |
WO2001086002A3 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis | |
WO2003009814A3 (en) | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer | |
WO2002071928A3 (en) | Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer | |
WO2002013847A3 (en) | Methods for diagnosis and therapy of hematological and virus-associated malignancies | |
WO2003004989A3 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
WO2001036977A3 (en) | Identification of disease markers involving mass-based-separation | |
WO2004056874A3 (en) | Neuropilin-1 inhibitors | |
WO2004048551A3 (en) | Target for therapy of cognitive impairment | |
WO2006028655A3 (en) | Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer | |
WO2003000012A3 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer | |
WO2004000094A3 (en) | Predictive markers in cancer therapy | |
WO2004067570A3 (en) | Prostate cancer diagnosis and treatment | |
WO2004106495A3 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
WO2002086448A3 (en) | Detection of microsatellite instability and its use in diagnosis of tumors | |
WO2005034732A3 (en) | Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer | |
WO2002022879A3 (en) | Detection of microsatellite instability and its use in diagnosis of tumors | |
WO2001042792A3 (en) | Diagnosis of cervical cancer using marker proteins | |
WO2002039122A3 (en) | Methods for the identification and the treatment of cardiovascular disease | |
WO2002044417A3 (en) | Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer | |
WO2002090925A3 (en) | Polypeptides and nucleic acids associated with cancer | |
WO2005005661A3 (en) | Genes regulated in ovarian cancer as prognostic and therapeutic targets | |
WO2002044419A3 (en) | Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer | |
WO2004029287A3 (en) | Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 155953 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2429721 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2003/004577 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002546765 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001987116 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002239363 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003/04997 Country of ref document: ZA Ref document number: 526706 Country of ref document: NZ Ref document number: 200304997 Country of ref document: ZA |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2001987116 Country of ref document: EP |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1/2-2/2, DRAWINGS, REPLACED BY NEW PAGES 1/2-2/2; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
WWP | Wipo information: published in national office |
Ref document number: 526706 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 526706 Country of ref document: NZ |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001987116 Country of ref document: EP |